New hope for tough prostate cancer? early trial launches
NCT ID NCT06830850
First seen Jan 16, 2026 · Last updated May 19, 2026 · Updated 20 times
Summary
This early-phase study tests a new drug called HRS-5041 in 25 men with metastatic castration-resistant prostate cancer (cancer that has spread and stopped responding to hormone therapy). The main goal is to check the drug's safety and how the body processes it. Participants will receive the drug and be monitored for side effects and cancer response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION RESISTANT PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cancer Research SA
RECRUITINGAdelaide, South Australia, Australia
Contact
Contact
-
Eastern Health (Box Hill Hospital)
RECRUITINGMelbourne, Australia
Contact
-
GenesisCare North Shore (Oncology)
RECRUITINGSydney, New South Wales, Australia
Contact
-
Icon Cancer Centre South Brisbane
RECRUITINGBrisbane, Australia
Contact
-
Illawarra Shoalhaven Local Health District (Wollongong Hospital)
RECRUITINGWollongong, Australia
Contact
-
John Flynn Private Hospital
RECRUITINGBrisbane, Australia
Contact
-
Linear Clinical Research Ltd
RECRUITINGPerth, Australia
Contact
-
MUPharm Pty Limited trading as Macquarie University Hospital Pharmacy
RECRUITINGSydney, Australia
Contact
Contact
-
Macquarie University
RECRUITINGSydney, Australia
Contact
-
Southern Oncology Clinical Research Unit
RECRUITINGAdelaide, South Australia, Australia
Contact
-
Sydney Adventist Hospital
RECRUITINGSydney, New South Wales, Australia
Contact
Conditions
Explore the condition pages connected to this study.